|
1
|
Miettinen M and Lasota J: Gastrointestinal
stromal tumors: pathology and prognosis at different sites. Semin
Diagn Pathol. 23:70–83. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Miettinen M and Lasota J: Gastrointestinal
stromal tumors: review on morphology, molecular pathology,
prognosis, and differential diagnosis. Arch Pathol Lab Med.
130:1466–1478. 2006.PubMed/NCBI
|
|
3
|
Reith JD, Goldblum JR, Lyles RH and Weiss
SW: Extragastrointestinal (soft tissue) stromal tumors: an analysis
of 48 cases with emphasis on histologic predictors of outcome. Mod
Pathol. 13:577–585. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ishikawa A, Teratani T, Ono S, et al: A
case of gastrointestinal stromal tumor with liver and bone
metastases effectively treated with radiofrequency ablation and
imatinib mesylate. Nihon Shokakibyo Gakkai Zasshi. 103:1274–1279.
2006.(In Japanese). PubMed/NCBI
|
|
5
|
Minami T, Sato S, Watanabe Y, et al:
Successful treatment of a gastrointestinal stromal tumor with liver
metastases in a case that tolerated imatinib administration, by
radiofrequency ablation using contrast-enhanced ultrasonography.
Nihon Shokakibyo Gakkai Zasshi. 107:442–448. 2010.(In Japanese).
PubMed/NCBI
|
|
6
|
DeMatteo RP, Lewis JJ, Leung D, Mudan SS,
Woodruff JM and Brennan MF: Two hundred gastrointestinal stromal
tumors: recurrence patterns and prognostic factors for survival.
Ann Surg. 231:51–58. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nunobe S, Sano T, Shimada K, Sakamoto Y
and Kosuge T: Surgery including liver resection for metastatic
gastrointestinal stromal tumors or gastrointestinal
leiomyosarcomas. Jpn J Clin Oncol. 35:338–341. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gomez D, Al-Mukthar A, Menon KV, Toogood
GJ, Lodge JP and Prasad KR: Aggressive surgical resection for the
management of hepatic metastases from gastrointestinal stromal
tumours: a single centre experience. HPB (Oxford). 9:64–70. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li L, Zhang J, Liu X, Li X, Jiao B and
Kang T: Clinical outcomes of radiofrequency ablation and surgical
resection for small hepatocellular carcinoma: a meta-analysis. J
Gastroenterol Hepatol. 1:51–58. 2012. View Article : Google Scholar
|
|
10
|
Yamanaka T, Takaki H, Nakatsuka A, et al:
Radiofrequency ablation for liver metastasis from gastrointestinal
stromal tumor. J Vasc Interv Radiol. 24:341–346. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jones RL, McCall J, Adam A, et al:
Radiofrequency ablation is a feasible therapeutic option in the
multi modality management of sarcoma. Eur J Surg Oncol. 36:477–482.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gastrointestinal Stromal Tumor
Meta-Analysis Group (MetaGIST), . Comparison of two doses of
imatinib for the treatment of unresectable or metastatic
gastrointestinal stromal tumors: a meta-analysis of 1,640 patients.
J Clin Oncol. 28:1247–1253. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Blanke CD, Demetri GD, von Mehren M, et
al: Long-term results from a randomized phase II trial of standard-
versus higher-dose imatinib mesylate for patients with unresectable
or metastatic gastrointestinal stromal tumors expressing KIT. J
Clin Oncol. 26:620–625. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Demetri GD, von Mehren M, Antonescu CR, et
al: NCCN Task Force report: update on the management of patients
with gastrointestinal stromal tumors. J Natl Compr Canc Netw.
8:S1–S41. 2010.PubMed/NCBI
|
|
15
|
Pawlik TM, Vauthey JN, Abdalla EK, Pollock
RE, Ellis LM and Curley SA: Results of a single-center experience
with resection and ablation for sarcoma metastatic to the liver.
Arch Surg. 141:537–543. 2006. View Article : Google Scholar : PubMed/NCBI
|
